- Home
- PFX vs TVGN Comparison
PFX vs TVGN Comparison
Compare PFX & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | PFX | TVGN |
|---|---|---|
| Founded | 2010 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Blank Checks |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.7M | 89.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PFX | TVGN |
|---|---|---|
| Price | $44.42 | $0.39 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 1.5K | ★ 1.5M |
| Earning Date | 02-06-2026 | 11-14-2025 |
| Dividend Yield | ★ 3.18% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.06 | N/A |
| Revenue | ★ $25,262,322.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $21.21 | ★ N/A |
| Revenue Growth | ★ 13.89 | N/A |
| 52 Week Low | $41.00 | $0.30 |
| 52 Week High | $57.40 | $1.92 |
Technical Indicators
Market Signals| Indicator | PFX | TVGN |
|---|---|---|
| Relative Strength Index (RSI) | 50.86 | 47.45 |
| Support Level | $43.01 | $0.34 |
| Resistance Level | $45.70 | $0.39 |
| Average True Range (ATR) | 0.94 | 0.03 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 45.04 | 78.62 |
Price Performance
Historical ComparisonAbout PFX PhenixFIN Corporation
PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.
About TVGN Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.